Login / Signup

Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study.

Beth HahnRichard H StanfordAlyssa Goolsby HunterBreanna EssoiJohn WhiteRiju Ray
Published in: Pulmonary therapy (2019)
GlaxoSmithKline (GSK study number: 205862).
Keyphrases
  • patient reported
  • chronic obstructive pulmonary disease
  • randomized controlled trial
  • signaling pathway
  • cross sectional
  • cystic fibrosis
  • lung function
  • air pollution
  • combination therapy
  • pi k akt
  • study protocol